Publicaciones científicas

Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis

01-nov-2022 | Revista: JACC. Cardiovascular Imaging

Thiago Quinaglia  1 , Carlos Gongora  2 , Magid Awadalla  2 , Malek Z O Hassan  2 , Amna Zafar  2 , Zsofia D Drobni  3 , Syed S Mahmood  4 , Lili Zhang  5 , Otavio R Coelho-Filho  6 , Giselle A Suero-Abreu  7 , Muhammad A Rizvi  8 , Gagan Sahni  9 , Anant Mandawat  10 , Eduardo Zatarain-Nicolás  11 , Michael Mahmoudi  12 , Ryan Sullivan  13 , Sarju Ganatra  14 , Lucie M Heinzerling  15 , Franck Thuny  16 , Stephane Ederhy  17 , Hannah K Gilman  2 , Supraja Sama  2 , Sofia Nikolaidou  2 , Ana González Mansilla  11 , Antonio Calles  11 , Marcella Cabral  18 , Francisco Fernández-Avilés  11 , Juan José Gavira  19 , Nahikari Salterain González  19 , Manuel García de Yébenes Castro  19 , Ana Barac  20 , Jonathan Afilalo  18 , Daniel A Zlotoff  21 , Leyre Zubiri  13 , Kerry L Reynolds  13 , Richard Devereux  22 , Judy Hung  23 , Michael H Picard  23 , Eric H Yang  24 , Dipti Gupta  4 , Caroline Michel  18 , Alexander R Lyon  25 , Carol L Chen  4 , Anju Nohria  26 , Michael G Fradley  27 , Paaladinesh Thavendiranathan  28 , Tomas G Neilan  29


Background: Global circumferential strain (GCS) and global radial strain (GRS) are reduced with cytotoxic chemotherapy. There are limited data on the effect of immune checkpoint inhibitor (ICI) myocarditis on GCS and GRS.

Objectives: This study aimed to detail the role of GCS and GRS in ICI myocarditis.

Methods: In this retrospective study, GCS and GRS from 75 cases of patients with ICI myocarditis and 50 ICI-treated patients without myocarditis (controls) were compared. Pre-ICI GCS and GRS were available for 12 cases and 50 controls. Measurements were performed in a core laboratory blinded to group and time. Major adverse cardiovascular events (MACEs) were defined as a composite of cardiogenic shock, cardiac arrest, complete heart block, and cardiac death.

Results: Cases and controls were similar in age (66 ± 15 years vs 63 ± 12 years; P = 0.20), sex (male: 73% vs 61%; P = 0.20) and cancer type (P = 0.08). Pre-ICI GCS and GRS were also similar (GCS: 22.6% ± 3.4% vs 23.5% ± 3.8%; P = 0.14; GRS: 45.5% ± 6.2% vs 43.6% ± 8.8%; P = 0.24). Overall, 56% (n = 42) of patients with myocarditis presented with preserved left ventricular ejection fraction (LVEF). GCS and GRS were lower in myocarditis compared with on-ICI controls (GCS: 17.5% ± 4.2% vs 23.6% ± 3.0%; P < 0.001; GRS: 28.6% ± 6.7% vs 47.0% ± 7.4%; P < 0.001). Over a median follow-up of 30 days, 28 cardiovascular events occurred. A GCS (HR: 4.9 [95% CI: 1.6-15.0]; P = 0.005) and GRS (HR: 3.9 [95% CI: 1.4-10.8]; P = 0.008) below the median was associated with an increased event rate. In receiver-operating characteristic (ROC) curves, GCS (AUC: 0.80 [95% CI: 0.70-0.91]) and GRS (AUC: 0.76 [95% CI: 0.64-0.88]) showed better performance than cardiac troponin T (cTnT) (AUC: 0.70 [95% CI: 0.58-0.82]), LVEF (AUC: 0.69 [95% CI: 0.56-0.81]), and age (AUC: 0.54 [95% CI: 0.40-0.68]). Net reclassification index and integrated discrimination improvement demonstrated incremental prognostic utility of GRS over LVEF (P = 0.04) and GCS over cTnT (P = 0.002).

Conclusions: GCS and GRS are lower in ICI myocarditis, and the magnitude of reduction has prognostic significance.

CITA DEL ARTÍCULO  JACC Cardiovasc Imaging. 2022 Nov;15(11):1883-1896.  doi: 10.1016/j.jcmg.2022.06.014. Epub 2022 Sep 14.